FDA Adverse Event Malfunction Summary report: N

COBAS B 101 HBA1C TEST

MDR report key: 9446524 · Received December 10, 2019

Report

Report Number
1823260-2019-04365
Event Type
Malfunction
Date Received
December 10, 2019
Date of Event
November 18, 2019
Report Date
December 26, 2019
Manufacturer
ROCHE DIAGNOSTICS
Product Code
LCP
PMA / PMN Number
K163633
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

RETENTION MATERIAL OF COBAS B101 HBA1C TEST DISCS OF LOT 931043-01 WAS TESTED AND NO DISCREPANT HBA1C RESULTS WERE RECEIVED. THE INVESTIGATION DID NOT IDENTIFY A PRODUCT PROBLEM. THE CAUSE OF THE EVENT COULD NOT BE DETERMINED.

Additional Manufacturer Narrative · 1

THE CUSTOMER'S METER WAS TESTED WITH QC MATERIAL. LEVEL 1: PASS, 5.1%, RANGE 4.3-6.5. LEVEL 2: PASS, 8.6%, RANGE 7.4-11.2. THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE INITIAL REPORTER RECEIVED A QUESTIONABLE HEMOGLOBIN A1C RESULT FOR ONE PATIENT SAMPLE FROM THE COBAS B 101 INSTRUMENT SERIAL NUMBER (B)(4). THE RESULT FROM THE B101 WAS 7.1 %. THE RESULT FROM ANOTHER LABORATORY USING AN UNKNOWN METHOD WAS 6.4 %. IT WAS NOT KNOWN IF ANY QUESTIONABLE RESULT WAS REPORTED OUTSIDE OF THE LABORATORY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1240528 COBAS B 101 HBA1C TEST ASSAY, GLYCOSYLATED HEMOGLOBIN LCP ROCHE DIAGNOSTICS B 101 HBA1C 931043-01

Patients

Seq Age Sex Outcome Treatment
1 71 YR